Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nr2f6
|
ENSMUSG00000002393.8 | nuclear receptor subfamily 2, group F, member 6 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr8_71382745_71382948 | Nr2f6 | 886 | 0.380363 | -0.57 | 4.7e-06 | Click! |
chr8_71383941_71384151 | Nr2f6 | 2086 | 0.158460 | -0.49 | 1.5e-04 | Click! |
chr8_71381974_71382671 | Nr2f6 | 362 | 0.739271 | -0.48 | 2.3e-04 | Click! |
chr8_71376455_71376623 | Nr2f6 | 749 | 0.448602 | 0.47 | 3.1e-04 | Click! |
chr8_71383540_71383882 | Nr2f6 | 1751 | 0.186036 | -0.43 | 1.0e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr9_124441790_124442379 | 122.27 |
Ppp2r3d |
protein phosphatase 2 (formerly 2A), regulatory subunit B'', delta |
662 |
0.65 |
chr9_124439906_124440949 | 67.43 |
Ppp2r3d |
protein phosphatase 2 (formerly 2A), regulatory subunit B'', delta |
441 |
0.79 |
chr5_112521223_112521397 | 61.82 |
Sez6l |
seizure related 6 homolog like |
46183 |
0.1 |
chr19_36553934_36555231 | 54.77 |
Hectd2 |
HECT domain E3 ubiquitin protein ligase 2 |
57 |
0.98 |
chr19_3912286_3912658 | 43.52 |
Ndufs8 |
NADH:ubiquinone oxidoreductase core subunit S8 |
16 |
0.94 |
chr8_122695553_122695753 | 42.79 |
Gm10612 |
predicted gene 10612 |
2207 |
0.17 |
chr15_95528851_95529002 | 41.60 |
Nell2 |
NEL-like 2 |
367 |
0.91 |
chr3_79628270_79629417 | 40.37 |
Etfdh |
electron transferring flavoprotein, dehydrogenase |
20 |
0.75 |
chr8_47284778_47285157 | 38.41 |
Stox2 |
storkhead box 2 |
4395 |
0.28 |
chr3_17619540_17619872 | 37.95 |
Gm38154 |
predicted gene, 38154 |
50982 |
0.17 |
chr12_102468744_102469733 | 35.48 |
Golga5 |
golgi autoantigen, golgin subfamily a, 5 |
46 |
0.97 |
chr2_92375145_92375948 | 33.43 |
Pex16 |
peroxisomal biogenesis factor 16 |
13 |
0.91 |
chr14_19808274_19808449 | 33.35 |
Nid2 |
nidogen 2 |
3125 |
0.21 |
chr11_95778785_95779287 | 32.46 |
Polr2k-ps |
polymerase (RNA) II (DNA directed) polypeptide K, pseudogene |
17545 |
0.11 |
chr16_77422153_77422336 | 32.12 |
9430053O09Rik |
RIKEN cDNA 9430053O09 gene |
424 |
0.74 |
chr17_27679167_27679824 | 31.64 |
Pacsin1 |
protein kinase C and casein kinase substrate in neurons 1 |
5686 |
0.12 |
chr17_6445889_6446624 | 30.54 |
Tmem181b-ps |
transmembrane protein 181B, pseudogene |
2839 |
0.21 |
chr8_120500387_120500853 | 30.53 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
12173 |
0.13 |
chr1_172018346_172018697 | 29.82 |
Vangl2 |
VANGL planar cell polarity 2 |
8190 |
0.14 |
chr19_10041145_10042475 | 28.45 |
Fads3 |
fatty acid desaturase 3 |
78 |
0.96 |
chr16_3843890_3844041 | 28.12 |
Zfp174 |
zinc finger protein 174 |
3303 |
0.12 |
chr13_71165659_71165842 | 28.01 |
Mir466f-4 |
microRNA 466f-4 |
58661 |
0.15 |
chr10_127066885_127067036 | 27.77 |
Cdk4 |
cyclin-dependent kinase 4 |
884 |
0.3 |
chr2_30718241_30719386 | 27.63 |
Gm14488 |
predicted gene 14488 |
1244 |
0.36 |
chr2_151740625_151741514 | 27.37 |
Psmf1 |
proteasome (prosome, macropain) inhibitor subunit 1 |
224 |
0.9 |
chr14_19808924_19809109 | 27.30 |
Nid2 |
nidogen 2 |
3780 |
0.19 |
chr2_174918449_174918600 | 26.72 |
Gm14616 |
predicted gene 14616 |
62235 |
0.09 |
chr7_31127074_31128340 | 26.00 |
Scn1b |
sodium channel, voltage-gated, type I, beta |
704 |
0.47 |
chr6_36776057_36776246 | 25.76 |
Ptn |
pleiotrophin |
34028 |
0.2 |
chr7_45460493_45461322 | 25.73 |
Ftl1 |
ferritin light polypeptide 1 |
1023 |
0.19 |
chr10_13982761_13983386 | 25.70 |
Hivep2 |
human immunodeficiency virus type I enhancer binding protein 2 |
16049 |
0.19 |
chr15_59040434_59041094 | 25.63 |
Mtss1 |
MTSS I-BAR domain containing 1 |
167 |
0.96 |
chr3_62458622_62458788 | 25.12 |
Dhx36 |
DEAH (Asp-Glu-Ala-His) box polypeptide 36 |
13882 |
0.24 |
chr17_34849679_34850038 | 25.09 |
Skiv2l |
superkiller viralicidic activity 2-like (S. cerevisiae) |
334 |
0.5 |
chr19_53449312_53449723 | 25.03 |
Mirt1 |
myocardial infarction associated transcript 1 |
1974 |
0.25 |
chr7_25068625_25068808 | 24.19 |
Grik5 |
glutamate receptor, ionotropic, kainate 5 (gamma 2) |
3385 |
0.14 |
chr6_72699485_72699773 | 23.33 |
Gm15402 |
predicted gene 15402 |
415 |
0.77 |
chr3_134237027_134237200 | 23.17 |
Cxxc4 |
CXXC finger 4 |
293 |
0.85 |
chr2_154421078_154421682 | 23.15 |
Snta1 |
syntrophin, acidic 1 |
13281 |
0.16 |
chr18_70568820_70569209 | 23.06 |
Mbd2 |
methyl-CpG binding domain protein 2 |
680 |
0.7 |
chr3_132017598_132017798 | 22.87 |
Gm22421 |
predicted gene, 22421 |
64694 |
0.11 |
chr4_98321737_98322101 | 22.66 |
0610025J13Rik |
RIKEN cDNA 0610025J13 gene |
471 |
0.8 |
chr7_12979544_12979864 | 22.59 |
Zfp446 |
zinc finger protein 446 |
184 |
0.86 |
chr1_169968566_169969463 | 22.53 |
Hsd17b7 |
hydroxysteroid (17-beta) dehydrogenase 7 |
227 |
0.67 |
chr14_55108115_55108607 | 22.52 |
Ap1g2 |
adaptor protein complex AP-1, gamma 2 subunit |
1768 |
0.17 |
chr19_56637292_56637443 | 22.42 |
Gm32441 |
predicted gene, 32441 |
27244 |
0.15 |
chr6_140603351_140603502 | 22.37 |
Gm44013 |
predicted gene, 44013 |
18997 |
0.17 |
chr2_25460257_25461283 | 22.15 |
Paxx |
non-homologous end joining factor |
106 |
0.9 |
chr13_104172611_104172762 | 21.98 |
Trappc13 |
trafficking protein particle complex 13 |
5721 |
0.15 |
chr14_20673851_20674037 | 21.83 |
Sec24c |
Sec24 related gene family, member C (S. cerevisiae) |
364 |
0.71 |
chr6_77075373_77076013 | 21.77 |
Ctnna2 |
catenin (cadherin associated protein), alpha 2 |
68250 |
0.13 |
chr18_42704469_42704620 | 21.75 |
C030004G16Rik |
RIKEN cDNA C030004G16 gene |
82085 |
0.08 |
chr12_26414308_26415459 | 21.28 |
Mir6538 |
microRNA 6538 |
127 |
0.66 |
chr9_27307997_27308174 | 21.26 |
Igsf9b |
immunoglobulin superfamily, member 9B |
8857 |
0.2 |
chr9_108460151_108461186 | 20.75 |
Ccdc71 |
coiled-coil domain containing 71 |
133 |
0.64 |
chr5_111595963_111596122 | 20.70 |
Gm42489 |
predicted gene 42489 |
2426 |
0.31 |
chr11_80316377_80316533 | 20.69 |
Rhbdl3 |
rhomboid like 3 |
3235 |
0.24 |
chr6_89333661_89333821 | 20.67 |
Plxna1 |
plexin A1 |
671 |
0.64 |
chr1_169919231_169919571 | 20.57 |
Ccdc190 |
coiled-coil domain containing 190 |
9247 |
0.17 |
chr5_53267260_53267782 | 20.48 |
Smim20 |
small integral membrane protein 20 |
331 |
0.88 |
chr7_49075385_49075536 | 20.24 |
Gm32849 |
predicted gene, 32849 |
9623 |
0.19 |
chr12_104677165_104677421 | 19.98 |
Dicer1 |
dicer 1, ribonuclease type III |
23209 |
0.21 |
chr10_79681206_79682337 | 19.82 |
Cdc34 |
cell division cycle 34 |
424 |
0.63 |
chr6_6248605_6248756 | 19.79 |
Gm20619 |
predicted gene 20619 |
7 |
0.98 |
chr10_78574631_78574817 | 19.77 |
Ilvbl |
ilvB (bacterial acetolactate synthase)-like |
137 |
0.9 |
chr3_34445413_34445747 | 19.70 |
Gm20515 |
predicted gene 20515 |
10483 |
0.18 |
chr12_3834339_3834973 | 19.68 |
Dnmt3a |
DNA methyltransferase 3A |
14979 |
0.17 |
chrX_49480554_49480737 | 19.47 |
Arhgap36 |
Rho GTPase activating protein 36 |
5030 |
0.25 |
chr10_39660796_39660947 | 19.39 |
Gm8899 |
predicted gene 8899 |
1218 |
0.34 |
chr10_37378360_37378791 | 19.30 |
Gm26535 |
predicted gene, 26535 |
41089 |
0.18 |
chr2_79369055_79369431 | 19.24 |
Cerkl |
ceramide kinase-like |
1622 |
0.37 |
chr18_75499294_75499593 | 19.12 |
Gm10532 |
predicted gene 10532 |
15202 |
0.25 |
chr13_76825112_76825289 | 18.96 |
Mctp1 |
multiple C2 domains, transmembrane 1 |
7 |
0.99 |
chr3_83583172_83583400 | 18.86 |
1700028M03Rik |
RIKEN cDNA 1700028M03 gene |
9164 |
0.27 |
chr8_8037970_8038121 | 18.80 |
Gm31401 |
predicted gene, 31401 |
28621 |
0.21 |
chr7_49298503_49298820 | 18.79 |
Nav2 |
neuron navigator 2 |
5477 |
0.26 |
chr8_97533410_97533561 | 18.67 |
Gm7191 |
predicted gene 7191 |
33107 |
0.22 |
chr11_110495799_110495950 | 18.58 |
Map2k6 |
mitogen-activated protein kinase kinase 6 |
16835 |
0.25 |
chr2_65931653_65932058 | 18.33 |
Csrnp3 |
cysteine-serine-rich nuclear protein 3 |
10 |
0.98 |
chr6_14898190_14898764 | 18.28 |
Foxp2 |
forkhead box P2 |
2872 |
0.41 |
chr2_144009561_144009970 | 18.28 |
Rrbp1 |
ribosome binding protein 1 |
1498 |
0.39 |
chr13_78200366_78200817 | 18.17 |
A830082K12Rik |
RIKEN cDNA A830082K12 gene |
813 |
0.37 |
chr5_134238139_134238290 | 18.10 |
Gtf2i |
general transcription factor II I |
2831 |
0.18 |
chr17_15068313_15068545 | 17.91 |
Ermard |
ER membrane associated RNA degradation |
2814 |
0.21 |
chr1_184503919_184504070 | 17.86 |
1700112H15Rik |
RIKEN cDNA 1700112H15 gene |
53697 |
0.11 |
chr12_39935011_39935162 | 17.86 |
Gm47868 |
predicted gene, 47868 |
12227 |
0.18 |
chr9_114528016_114528485 | 17.58 |
C130032M10Rik |
RIKEN cDNA C130032M10 gene |
12553 |
0.16 |
chr8_72646247_72646404 | 17.22 |
Nwd1 |
NACHT and WD repeat domain containing 1 |
386 |
0.82 |
chr10_14977358_14977509 | 17.17 |
Gm23892 |
predicted gene, 23892 |
7237 |
0.25 |
chr3_115887556_115888230 | 17.06 |
A930005H10Rik |
RIKEN cDNA A930005H10 gene |
6 |
0.51 |
chr9_74324190_74324565 | 17.04 |
Gm24141 |
predicted gene, 24141 |
38233 |
0.16 |
chr14_78850676_78851236 | 17.02 |
Vwa8 |
von Willebrand factor A domain containing 8 |
1702 |
0.34 |
chr11_63861957_63862493 | 17.00 |
Hmgb1-ps3 |
high mobility group box 1, pseudogene 3 |
15407 |
0.21 |
chr7_107596874_107597025 | 16.93 |
Ppfibp2 |
PTPRF interacting protein, binding protein 2 (liprin beta 2) |
1664 |
0.29 |
chr6_125163930_125164575 | 16.74 |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
664 |
0.41 |
chr19_27607032_27607183 | 16.73 |
Gm50101 |
predicted gene, 50101 |
94599 |
0.08 |
chr8_70348535_70348753 | 16.55 |
Upf1 |
UPF1 regulator of nonsense transcripts homolog (yeast) |
4567 |
0.12 |
chr5_30920760_30922186 | 16.54 |
Khk |
ketohexokinase |
42 |
0.93 |
chr7_141468254_141469266 | 16.50 |
Cd151 |
CD151 antigen |
62 |
0.89 |
chr1_133083991_133084552 | 16.40 |
Pik3c2b |
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta |
15692 |
0.13 |
chr8_71469378_71469964 | 16.33 |
Dda1 |
DET1 and DDB1 associated 1 |
386 |
0.69 |
chr17_56405416_56405574 | 16.26 |
Ptprs |
protein tyrosine phosphatase, receptor type, S |
8935 |
0.13 |
chr17_43157845_43158231 | 16.25 |
E130008D07Rik |
RIKEN cDNA E130008D07 gene |
158 |
0.97 |
chr3_107460175_107460519 | 16.20 |
Kcnc4 |
potassium voltage gated channel, Shaw-related subfamily, member 4 |
795 |
0.62 |
chr3_92638470_92638629 | 16.18 |
Lce1a1 |
late cornified envelope 1A1 |
9758 |
0.08 |
chr7_140081338_140081688 | 16.11 |
Caly |
calcyon neuron-specific vesicular protein |
714 |
0.46 |
chr12_16553509_16553660 | 16.09 |
Lpin1 |
lipin 1 |
8454 |
0.26 |
chr6_142756817_142757415 | 15.96 |
Cmas |
cytidine monophospho-N-acetylneuraminic acid synthetase |
341 |
0.89 |
chr10_69583868_69584467 | 15.96 |
Gm46231 |
predicted gene, 46231 |
17806 |
0.24 |
chr9_96493315_96493466 | 15.93 |
Gm27289 |
predicted gene, 27289 |
1823 |
0.25 |
chr3_61255168_61255319 | 15.89 |
Gm37719 |
predicted gene, 37719 |
36203 |
0.18 |
chr1_156997537_156997815 | 15.89 |
Gm10531 |
predicted gene 10531 |
45871 |
0.11 |
chr15_85708879_85709635 | 15.85 |
Mirlet7b |
microRNA let7b |
1938 |
0.23 |
chr3_116513217_116513638 | 15.75 |
Dbt |
dihydrolipoamide branched chain transacylase E2 |
299 |
0.81 |
chr1_177449775_177449926 | 15.72 |
Zbtb18 |
zinc finger and BTB domain containing 18 |
4029 |
0.18 |
chr12_3236518_3237725 | 15.68 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
510 |
0.74 |
chr2_30647878_30648063 | 15.63 |
9330198N18Rik |
RIKEN cDNA 9330198N18 gene |
18315 |
0.14 |
chr19_56519434_56519737 | 15.60 |
Dclre1a |
DNA cross-link repair 1A |
17797 |
0.17 |
chr6_91014759_91014910 | 15.57 |
Nup210 |
nucleoporin 210 |
2595 |
0.28 |
chr7_25153502_25153841 | 15.54 |
D930028M14Rik |
RIKEN cDNA D930028M14 gene |
1214 |
0.33 |
chr11_49624301_49624452 | 15.52 |
Flt4 |
FMS-like tyrosine kinase 4 |
15113 |
0.11 |
chr12_98520224_98520514 | 15.51 |
Gm40893 |
predicted gene, 40893 |
3475 |
0.21 |
chr11_8811726_8811877 | 15.46 |
Gm11990 |
predicted gene 11990 |
4953 |
0.27 |
chr14_118042149_118042436 | 15.36 |
Dct |
dopachrome tautomerase |
837 |
0.6 |
chr16_92215868_92216019 | 15.33 |
Gm29880 |
predicted gene, 29880 |
8455 |
0.15 |
chr6_54939654_54939952 | 15.31 |
Nod1 |
nucleotide-binding oligomerization domain containing 1 |
48 |
0.97 |
chr16_65718891_65719042 | 15.30 |
Gm5221 |
predicted gene 5221 |
74405 |
0.1 |
chr3_103605836_103605987 | 15.25 |
Gm43066 |
predicted gene 43066 |
3968 |
0.18 |
chr3_27196680_27196831 | 15.23 |
Nceh1 |
neutral cholesterol ester hydrolase 1 |
8314 |
0.19 |
chr5_34182958_34183168 | 15.11 |
Mxd4 |
Max dimerization protein 4 |
1307 |
0.27 |
chr5_18273468_18273619 | 15.06 |
Gm3527 |
predicted gene 3527 |
76805 |
0.11 |
chr19_60055333_60055484 | 15.05 |
Csf1r-ps |
colony stimulating factor 1 receptor (granulocyte), pseudogene |
24024 |
0.18 |
chr1_57406409_57406862 | 15.04 |
Tyw5 |
tRNA-yW synthesizing protein 5 |
39 |
0.6 |
chr4_141312456_141313176 | 14.92 |
Epha2 |
Eph receptor A2 |
3922 |
0.13 |
chr15_3236385_3236684 | 14.88 |
Gm7962 |
predicted gene 7962 |
16836 |
0.19 |
chr15_83710199_83710350 | 14.76 |
Scube1 |
signal peptide, CUB domain, EGF-like 1 |
14652 |
0.21 |
chr4_101419063_101420491 | 14.73 |
Ak4 |
adenylate kinase 4 |
44 |
0.97 |
chr11_117436797_117437102 | 14.70 |
Gm11732 |
predicted gene 11732 |
10771 |
0.14 |
chr6_124812248_124812629 | 14.70 |
Tpi1 |
triosephosphate isomerase 1 |
402 |
0.62 |
chr8_85554792_85555798 | 14.66 |
Dnaja2 |
DnaJ heat shock protein family (Hsp40) member A2 |
49 |
0.97 |
chr8_120565059_120565244 | 14.64 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
2528 |
0.16 |
chr13_73328155_73328670 | 14.50 |
Ndufs6 |
NADH:ubiquinone oxidoreductase core subunit S6 |
40 |
0.57 |
chr9_99435782_99436227 | 14.47 |
Mras |
muscle and microspikes RAS |
922 |
0.54 |
chrX_73476653_73476993 | 14.46 |
Bgn |
biglycan |
6779 |
0.12 |
chr13_112288004_112288571 | 14.39 |
Ankrd55 |
ankyrin repeat domain 55 |
164 |
0.95 |
chr5_103335878_103336033 | 14.36 |
Gm42619 |
predicted gene 42619 |
8017 |
0.16 |
chr4_134307339_134307789 | 14.34 |
Trim63 |
tripartite motif-containing 63 |
7556 |
0.1 |
chr15_86214264_86214964 | 14.32 |
Tbc1d22a |
TBC1 domain family, member 22a |
155 |
0.94 |
chr2_38976122_38976273 | 14.29 |
Gm13474 |
predicted gene 13474 |
2250 |
0.16 |
chr13_101813325_101813516 | 14.26 |
Gm19108 |
predicted gene, 19108 |
28886 |
0.16 |
chr2_158794072_158795253 | 14.25 |
Dhx35 |
DEAH (Asp-Glu-Ala-His) box polypeptide 35 |
145 |
0.96 |
chr14_4183274_4183610 | 14.21 |
Gm2974 |
predicted gene 2974 |
866 |
0.5 |
chr6_47390560_47390907 | 14.16 |
Gm18584 |
predicted gene, 18584 |
42356 |
0.15 |
chr10_94553188_94553468 | 14.16 |
Tmcc3 |
transmembrane and coiled coil domains 3 |
2456 |
0.27 |
chr4_36014235_36014463 | 14.12 |
Gm12369 |
predicted gene 12369 |
10170 |
0.27 |
chr10_67549265_67549730 | 14.10 |
Ado |
2-aminoethanethiol (cysteamine) dioxygenase |
429 |
0.76 |
chr14_62446247_62446398 | 14.09 |
Gucy1b2 |
guanylate cyclase 1, soluble, beta 2 |
8471 |
0.18 |
chr7_16119631_16120684 | 14.07 |
Kptn |
kaptin |
62 |
0.96 |
chr2_174294955_174296140 | 14.04 |
Gnasas1 |
GNAS antisense RNA 1 |
111 |
0.94 |
chr13_57573656_57573807 | 14.03 |
Gm48176 |
predicted gene, 48176 |
297053 |
0.01 |
chr1_172058385_172058793 | 14.02 |
Nhlh1 |
nescient helix loop helix 1 |
1016 |
0.38 |
chr18_60770031_60770182 | 14.02 |
Rps14 |
ribosomal protein S14 |
4490 |
0.15 |
chr14_68981312_68981674 | 13.94 |
Stc1 |
stanniocalcin 1 |
47745 |
0.13 |
chr4_122998402_122999232 | 13.90 |
Mycl |
v-myc avian myelocytomatosis viral oncogene lung carcinoma derived |
63 |
0.96 |
chr3_149381639_149381813 | 13.90 |
Gm26468 |
predicted gene, 26468 |
40718 |
0.16 |
chr9_96980387_96981016 | 13.75 |
Spsb4 |
splA/ryanodine receptor domain and SOCS box containing 4 |
3494 |
0.21 |
chr17_86479481_86479632 | 13.67 |
Prkce |
protein kinase C, epsilon |
11006 |
0.23 |
chr11_18982338_18982489 | 13.67 |
2610001A08Rik |
RIKEN cDNA 2610001A08 gene |
24060 |
0.13 |
chr1_184809475_184809794 | 13.66 |
Mtarc1 |
mitochondrial amidoxime reducing component 1 |
781 |
0.57 |
chr4_119259443_119259594 | 13.64 |
Gm12927 |
predicted gene 12927 |
2543 |
0.13 |
chr3_37420152_37420343 | 13.61 |
Nudt6 |
nudix (nucleoside diphosphate linked moiety X)-type motif 6 |
36 |
0.5 |
chr5_142367069_142368113 | 13.56 |
Foxk1 |
forkhead box K1 |
33906 |
0.18 |
chr15_34510882_34511033 | 13.56 |
Pop1 |
processing of precursor 1, ribonuclease P/MRP family, (S. cerevisiae) |
1050 |
0.39 |
chr12_28688268_28688419 | 13.50 |
Mir6937 |
microRNA 6937 |
9018 |
0.13 |
chr8_48599175_48599326 | 13.50 |
Gm45772 |
predicted gene 45772 |
31919 |
0.2 |
chr3_135290410_135290600 | 13.48 |
Bdh2 |
3-hydroxybutyrate dehydrogenase, type 2 |
1847 |
0.28 |
chr6_120490984_120491135 | 13.44 |
Tmem121b |
transmembrane protein 121B |
2748 |
0.18 |
chr5_81662076_81662227 | 13.41 |
Adgrl3 |
adhesion G protein-coupled receptor L3 |
1848 |
0.46 |
chr16_76453512_76454073 | 13.38 |
Gm45030 |
predicted gene 45030 |
49117 |
0.12 |
chr15_74567371_74567522 | 13.34 |
Adgrb1 |
adhesion G protein-coupled receptor B1 |
3509 |
0.19 |
chr7_73637071_73637452 | 13.27 |
Gm44737 |
predicted gene 44737 |
6644 |
0.1 |
chr3_145646156_145646348 | 13.25 |
Ccn1 |
cellular communication network factor 1 |
3729 |
0.22 |
chr1_150392415_150392953 | 13.21 |
Odr4 |
odr4 GPCR localization factor homolog |
35 |
0.65 |
chr17_87611074_87611259 | 13.19 |
Epcam |
epithelial cell adhesion molecule |
24813 |
0.15 |
chr1_189789623_189789889 | 13.14 |
Ptpn14 |
protein tyrosine phosphatase, non-receptor type 14 |
3084 |
0.25 |
chr3_131271140_131271491 | 13.04 |
Hadh |
hydroxyacyl-Coenzyme A dehydrogenase |
709 |
0.63 |
chr1_106629505_106629752 | 13.01 |
Gm37053 |
predicted gene, 37053 |
22758 |
0.19 |
chr16_20696316_20696665 | 12.94 |
Fam131a |
family with sequence similarity 131, member A |
315 |
0.74 |
chr5_31201973_31202166 | 12.93 |
Zfp513 |
zinc finger protein 513 |
27 |
0.93 |
chr11_120617005_120617272 | 12.92 |
Pcyt2 |
phosphate cytidylyltransferase 2, ethanolamine |
731 |
0.32 |
chr11_109702067_109702257 | 12.90 |
Fam20a |
family with sequence similarity 20, member A |
19183 |
0.16 |
chr1_44101573_44102245 | 12.87 |
Tex30 |
testis expressed 30 |
104 |
0.94 |
chr18_84921773_84922047 | 12.86 |
Fbxo15 |
F-box protein 15 |
12872 |
0.17 |
chr2_156066320_156066471 | 12.85 |
Spag4 |
sperm associated antigen 4 |
340 |
0.76 |
chr9_118506366_118507194 | 12.83 |
Golga4 |
golgi autoantigen, golgin subfamily a, 4 |
329 |
0.85 |
chr12_117344591_117345571 | 12.82 |
Gm5441 |
predicted gene 5441 |
8059 |
0.29 |
chr9_21072992_21073837 | 12.81 |
Fdx2 |
ferredoxin 2 |
92 |
0.74 |
chr18_50045910_50046083 | 12.79 |
Tnfaip8 |
tumor necrosis factor, alpha-induced protein 8 |
744 |
0.68 |
chr17_84008803_84008954 | 12.77 |
8430430B14Rik |
RIKEN cDNA 8430430B14 gene |
16 |
0.96 |
chr11_4987119_4987384 | 12.76 |
Ap1b1 |
adaptor protein complex AP-1, beta 1 subunit |
317 |
0.85 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.9 | 31.6 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
6.9 | 27.6 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
5.0 | 15.1 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
4.3 | 21.4 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
4.1 | 12.4 | GO:0046684 | response to pyrethroid(GO:0046684) |
3.6 | 36.1 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
3.1 | 9.3 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
3.1 | 9.2 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
3.0 | 9.1 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
2.8 | 8.4 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
2.8 | 13.8 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
2.7 | 8.2 | GO:0046075 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
2.7 | 133.6 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
2.7 | 43.1 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
2.6 | 7.7 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
2.5 | 9.8 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
2.4 | 14.6 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
2.4 | 41.3 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
2.4 | 4.8 | GO:0061346 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
2.3 | 2.3 | GO:0009196 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
2.3 | 6.9 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
2.3 | 6.9 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
2.3 | 6.8 | GO:1990034 | calcium ion export from cell(GO:1990034) |
2.2 | 11.2 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
2.2 | 4.4 | GO:0046098 | guanine metabolic process(GO:0046098) |
2.2 | 4.3 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
2.1 | 6.2 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
2.1 | 6.2 | GO:0015755 | fructose transport(GO:0015755) |
2.0 | 8.2 | GO:0010288 | response to lead ion(GO:0010288) |
2.0 | 8.1 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
2.0 | 7.9 | GO:0006742 | NADP catabolic process(GO:0006742) |
1.9 | 5.8 | GO:1902896 | terminal web assembly(GO:1902896) |
1.9 | 13.5 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
1.9 | 34.8 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
1.9 | 7.6 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
1.9 | 5.7 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
1.9 | 3.7 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
1.8 | 5.3 | GO:0021564 | vagus nerve development(GO:0021564) |
1.8 | 10.5 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
1.7 | 6.7 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
1.6 | 15.9 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
1.6 | 14.1 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
1.5 | 4.5 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
1.5 | 4.4 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
1.4 | 10.1 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
1.4 | 4.3 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
1.4 | 2.8 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
1.4 | 4.1 | GO:0070827 | chromatin maintenance(GO:0070827) |
1.4 | 5.5 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
1.4 | 16.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
1.3 | 17.4 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
1.3 | 5.3 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
1.3 | 10.7 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
1.3 | 1.3 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
1.3 | 2.7 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
1.3 | 3.9 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
1.3 | 2.6 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
1.3 | 3.9 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
1.3 | 7.7 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
1.3 | 5.1 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
1.3 | 5.0 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
1.2 | 4.9 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
1.2 | 4.8 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
1.2 | 3.5 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
1.2 | 6.9 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
1.1 | 8.0 | GO:0070431 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
1.1 | 13.7 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
1.1 | 2.2 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
1.1 | 1.1 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
1.1 | 4.3 | GO:0008355 | olfactory learning(GO:0008355) |
1.1 | 4.3 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
1.1 | 2.1 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
1.0 | 12.6 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
1.0 | 3.1 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
1.0 | 3.1 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
1.0 | 9.1 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.0 | 11.7 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
1.0 | 2.9 | GO:1903011 | negative regulation of bone development(GO:1903011) |
1.0 | 9.6 | GO:0051198 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
1.0 | 10.5 | GO:0018119 | peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.9 | 2.8 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.9 | 2.8 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.9 | 2.8 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.9 | 11.9 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.9 | 5.5 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.9 | 1.8 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.9 | 2.7 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.9 | 3.6 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.9 | 3.6 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.9 | 2.7 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.9 | 0.9 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.9 | 2.6 | GO:1904193 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.9 | 13.0 | GO:0042026 | protein refolding(GO:0042026) |
0.9 | 7.7 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.8 | 5.9 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.8 | 9.2 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.8 | 9.8 | GO:0070723 | response to cholesterol(GO:0070723) |
0.8 | 4.1 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.8 | 2.4 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.8 | 5.6 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.8 | 0.8 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.8 | 2.3 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.8 | 3.1 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.8 | 0.8 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.8 | 5.3 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.7 | 0.7 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
0.7 | 1.5 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.7 | 8.2 | GO:0070166 | enamel mineralization(GO:0070166) |
0.7 | 1.5 | GO:0061419 | positive regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061419) |
0.7 | 7.9 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.7 | 0.7 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.7 | 3.6 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.7 | 9.1 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.7 | 5.6 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
0.7 | 1.4 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.7 | 4.2 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.7 | 2.8 | GO:0008228 | opsonization(GO:0008228) |
0.7 | 2.8 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.7 | 9.6 | GO:0019682 | glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.7 | 4.1 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.7 | 2.0 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.7 | 3.4 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.7 | 0.7 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.7 | 2.0 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.7 | 9.8 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.7 | 3.9 | GO:0006477 | protein sulfation(GO:0006477) |
0.6 | 9.1 | GO:0015858 | nucleoside transport(GO:0015858) |
0.6 | 1.9 | GO:0048320 | axial mesoderm formation(GO:0048320) |
0.6 | 2.6 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.6 | 3.8 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.6 | 1.9 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.6 | 5.7 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.6 | 3.1 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.6 | 0.6 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.6 | 1.2 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.6 | 4.9 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.6 | 1.8 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.6 | 2.4 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.6 | 1.8 | GO:0071733 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
0.6 | 9.0 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.6 | 2.4 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.6 | 1.8 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.6 | 2.4 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.6 | 2.4 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.6 | 1.2 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.6 | 4.7 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.6 | 2.3 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.6 | 1.8 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.6 | 4.7 | GO:1904152 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) regulation of retrograde protein transport, ER to cytosol(GO:1904152) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.6 | 1.7 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.6 | 1.2 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.6 | 4.0 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.6 | 5.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.6 | 6.3 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.6 | 1.1 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.6 | 6.3 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
0.6 | 8.0 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.6 | 4.0 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.6 | 0.6 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.6 | 6.1 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.6 | 1.1 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.6 | 1.7 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.5 | 2.2 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.5 | 3.3 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
0.5 | 8.2 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.5 | 0.5 | GO:0035912 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
0.5 | 1.6 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.5 | 3.8 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.5 | 1.1 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.5 | 3.7 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.5 | 0.5 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.5 | 1.6 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.5 | 29.4 | GO:1901799 | negative regulation of proteasomal protein catabolic process(GO:1901799) |
0.5 | 1.0 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.5 | 1.6 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.5 | 3.6 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.5 | 3.6 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.5 | 10.8 | GO:1902668 | negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
0.5 | 5.1 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.5 | 1.5 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.5 | 4.0 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.5 | 1.5 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.5 | 1.5 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.5 | 1.5 | GO:0034214 | protein hexamerization(GO:0034214) |
0.5 | 8.7 | GO:0044804 | nucleophagy(GO:0044804) |
0.5 | 3.8 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.5 | 0.5 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.5 | 0.9 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.5 | 1.9 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.5 | 0.9 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.5 | 6.4 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.5 | 0.9 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.4 | 4.0 | GO:0001553 | luteinization(GO:0001553) |
0.4 | 1.3 | GO:0000436 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) |
0.4 | 1.3 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.4 | 0.9 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.4 | 2.2 | GO:0021764 | amygdala development(GO:0021764) |
0.4 | 1.3 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.4 | 2.6 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.4 | 0.9 | GO:0002432 | granuloma formation(GO:0002432) |
0.4 | 2.1 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
0.4 | 0.4 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.4 | 0.4 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.4 | 0.8 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
0.4 | 1.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.4 | 1.2 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.4 | 5.4 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.4 | 1.2 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.4 | 3.3 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.4 | 0.8 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.4 | 4.5 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.4 | 1.6 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.4 | 0.4 | GO:0097252 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) oligodendrocyte apoptotic process(GO:0097252) regulation of interleukin-5 secretion(GO:2000662) regulation of interleukin-13 secretion(GO:2000665) |
0.4 | 0.4 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
0.4 | 0.4 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.4 | 1.6 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.4 | 2.8 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.4 | 2.4 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.4 | 2.8 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.4 | 2.4 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.4 | 10.2 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.4 | 1.2 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.4 | 0.8 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
0.4 | 1.9 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.4 | 0.4 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.4 | 1.1 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.4 | 0.4 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.4 | 1.1 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.4 | 1.1 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.4 | 2.2 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.4 | 1.8 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.4 | 0.7 | GO:0021586 | pons maturation(GO:0021586) |
0.4 | 0.4 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.4 | 4.8 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.4 | 1.1 | GO:0002159 | desmosome assembly(GO:0002159) |
0.4 | 1.5 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.4 | 0.7 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.4 | 7.4 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.3 | 2.4 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.3 | 0.3 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.3 | 44.5 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.3 | 1.4 | GO:1902837 | amino acid import into cell(GO:1902837) |
0.3 | 0.7 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.3 | 0.3 | GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
0.3 | 0.3 | GO:0061054 | dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) |
0.3 | 1.7 | GO:0090239 | regulation of histone H4 acetylation(GO:0090239) |
0.3 | 1.3 | GO:0050955 | thermoception(GO:0050955) |
0.3 | 1.3 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.3 | 1.0 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.3 | 1.0 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.3 | 0.3 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.3 | 2.3 | GO:0032986 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.3 | 3.9 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.3 | 9.2 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.3 | 1.9 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.3 | 1.0 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.3 | 2.5 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.3 | 1.3 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
0.3 | 1.9 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.3 | 4.4 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.3 | 20.5 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.3 | 1.2 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.3 | 0.3 | GO:0048294 | negative regulation of isotype switching(GO:0045829) negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.3 | 4.6 | GO:0034389 | lipid particle organization(GO:0034389) |
0.3 | 0.9 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.3 | 0.3 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) |
0.3 | 0.9 | GO:0070459 | prolactin secretion(GO:0070459) |
0.3 | 0.6 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.3 | 0.3 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
0.3 | 4.3 | GO:0002063 | chondrocyte development(GO:0002063) |
0.3 | 2.4 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.3 | 0.3 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.3 | 1.2 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.3 | 0.3 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
0.3 | 0.6 | GO:0072553 | terminal button organization(GO:0072553) |
0.3 | 9.9 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.3 | 1.2 | GO:0036490 | regulation of translation in response to endoplasmic reticulum stress(GO:0036490) regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.3 | 1.2 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.3 | 3.2 | GO:0051647 | nucleus localization(GO:0051647) |
0.3 | 0.6 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.3 | 0.9 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.3 | 0.9 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.3 | 2.3 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.3 | 0.6 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.3 | 0.9 | GO:1903416 | response to glycoside(GO:1903416) |
0.3 | 0.3 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.3 | 0.3 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.3 | 1.2 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.3 | 0.9 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.3 | 3.8 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.3 | 4.0 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
0.3 | 14.9 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.3 | 0.3 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.3 | 1.7 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.3 | 1.7 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.3 | 0.8 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
0.3 | 0.3 | GO:0072422 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.3 | 1.7 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.3 | 5.8 | GO:0097178 | ruffle assembly(GO:0097178) |
0.3 | 1.9 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.3 | 0.5 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.3 | 2.2 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.3 | 0.5 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.3 | 0.3 | GO:2000849 | glucocorticoid secretion(GO:0035933) regulation of glucocorticoid secretion(GO:2000849) positive regulation of glucocorticoid secretion(GO:2000851) |
0.3 | 0.5 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.3 | 0.3 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.3 | 0.5 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.3 | 1.3 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.3 | 4.0 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.3 | 2.1 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.3 | 0.3 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.3 | 1.3 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
0.3 | 0.5 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.3 | 1.3 | GO:0019695 | choline metabolic process(GO:0019695) |
0.3 | 0.8 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.3 | 1.0 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.3 | 0.5 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.3 | 1.5 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.3 | 0.3 | GO:0060613 | fat pad development(GO:0060613) |
0.3 | 0.5 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.3 | 2.3 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.3 | 0.5 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.3 | 3.3 | GO:0097320 | membrane tubulation(GO:0097320) |
0.3 | 2.3 | GO:0070986 | left/right axis specification(GO:0070986) |
0.3 | 11.4 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.3 | 0.5 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.3 | 4.3 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.3 | 0.8 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.3 | 0.5 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.3 | 0.5 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.2 | 0.2 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.2 | 0.2 | GO:0060761 | negative regulation of response to cytokine stimulus(GO:0060761) |
0.2 | 0.7 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.2 | 0.2 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.2 | 1.5 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.2 | 2.0 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.2 | 0.7 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.2 | 1.2 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.2 | 0.7 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.2 | 1.4 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.2 | 0.9 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.2 | 0.9 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.2 | 0.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 1.2 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.2 | 1.2 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.2 | 0.5 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.2 | 0.9 | GO:0070295 | renal water absorption(GO:0070295) |
0.2 | 0.5 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.2 | 0.2 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.2 | 0.5 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.2 | 0.7 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.2 | 0.7 | GO:0061724 | lipophagy(GO:0061724) |
0.2 | 1.4 | GO:0022038 | corpus callosum development(GO:0022038) |
0.2 | 4.7 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.2 | 2.0 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.2 | 0.4 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.2 | 0.7 | GO:0045064 | T-helper 2 cell differentiation(GO:0045064) |
0.2 | 1.8 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.2 | 0.7 | GO:0042637 | catagen(GO:0042637) |
0.2 | 0.4 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.2 | 10.0 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
0.2 | 0.7 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.2 | 1.1 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.2 | 0.9 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) |
0.2 | 0.2 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.2 | 0.7 | GO:0045922 | negative regulation of fatty acid metabolic process(GO:0045922) |
0.2 | 3.7 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.2 | 0.4 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.2 | 0.9 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.2 | 0.2 | GO:0043309 | regulation of eosinophil degranulation(GO:0043309) |
0.2 | 0.4 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.2 | 1.0 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.2 | 1.9 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.2 | 0.4 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
0.2 | 0.4 | GO:0014029 | neural crest formation(GO:0014029) |
0.2 | 0.4 | GO:0043134 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
0.2 | 0.6 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.2 | 0.2 | GO:0021823 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.2 | 0.4 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.2 | 0.4 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.2 | 0.2 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.2 | 0.6 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.2 | 1.0 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.2 | 0.4 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.2 | 1.6 | GO:0050932 | regulation of pigment cell differentiation(GO:0050932) |
0.2 | 0.2 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.2 | 9.9 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.2 | 2.9 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.2 | 2.4 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.2 | 0.2 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.2 | 1.0 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.2 | 1.0 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.2 | 3.5 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.2 | 0.2 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.2 | 5.6 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.2 | 0.4 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
0.2 | 0.6 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.2 | 0.8 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.2 | 0.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.2 | 0.6 | GO:0060486 | Clara cell differentiation(GO:0060486) |
0.2 | 0.8 | GO:0032826 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.2 | 0.8 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.2 | 0.2 | GO:0071899 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.2 | 0.9 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.2 | 0.4 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.2 | 0.7 | GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
0.2 | 0.4 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.2 | 1.7 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.2 | 0.2 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.2 | 1.1 | GO:0009651 | response to salt stress(GO:0009651) |
0.2 | 0.9 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.2 | 1.5 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.2 | 0.7 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.2 | 1.1 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.2 | 1.1 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.2 | 0.9 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.2 | 1.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.2 | 0.7 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.2 | 0.2 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.2 | 5.3 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.2 | 1.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.2 | 0.2 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.2 | 0.5 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
0.2 | 0.3 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.2 | 0.5 | GO:0050711 | negative regulation of interleukin-1 secretion(GO:0050711) |
0.2 | 1.0 | GO:0097264 | self proteolysis(GO:0097264) |
0.2 | 0.7 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.2 | 0.3 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.2 | 0.9 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.2 | 0.3 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
0.2 | 0.8 | GO:0070861 | regulation of protein exit from endoplasmic reticulum(GO:0070861) |
0.2 | 0.5 | GO:0014741 | negative regulation of muscle hypertrophy(GO:0014741) |
0.2 | 0.2 | GO:0017085 | response to insecticide(GO:0017085) |
0.2 | 0.3 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.2 | 1.0 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) |
0.2 | 1.3 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.2 | 1.8 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.2 | 13.2 | GO:0030178 | negative regulation of Wnt signaling pathway(GO:0030178) |
0.2 | 1.0 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.2 | 0.3 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.2 | 0.5 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.2 | 3.1 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.2 | 0.3 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.2 | 0.3 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.2 | 0.5 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.2 | 0.5 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.2 | 1.8 | GO:0036065 | fucosylation(GO:0036065) |
0.2 | 0.2 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
0.2 | 0.3 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.2 | 0.8 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.2 | 0.6 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.2 | 0.5 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.2 | 0.3 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.2 | 3.5 | GO:0010761 | fibroblast migration(GO:0010761) |
0.2 | 1.3 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.2 | 0.9 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.2 | 0.6 | GO:0021779 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.2 | 0.2 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.2 | 0.5 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.2 | 0.5 | GO:1903147 | negative regulation of mitophagy(GO:1903147) |
0.2 | 0.5 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.2 | 2.3 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.2 | 9.6 | GO:0035195 | gene silencing by miRNA(GO:0035195) |
0.2 | 0.2 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.2 | 0.3 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.2 | 0.5 | GO:0002584 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.2 | 3.1 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.2 | 0.5 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 0.2 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.2 | 0.2 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.2 | 0.9 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.2 | 0.6 | GO:0046959 | habituation(GO:0046959) |
0.2 | 0.5 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.1 | 1.0 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.1 | 1.6 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.1 | 1.2 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 5.7 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.9 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 2.5 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.1 | 1.5 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.1 | 0.6 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.1 | 0.9 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.1 | 1.6 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.1 | 5.5 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.1 | 0.6 | GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
0.1 | 0.1 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.1 | 0.3 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.1 | 0.3 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.1 | 0.6 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
0.1 | 0.6 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.1 | 2.0 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.1 | 1.8 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 0.6 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.6 | GO:0034351 | negative regulation of glial cell apoptotic process(GO:0034351) |
0.1 | 1.1 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.8 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 1.8 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.1 | 0.8 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 0.4 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 0.6 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.1 | 0.7 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.1 | 1.7 | GO:0002507 | tolerance induction(GO:0002507) |
0.1 | 0.4 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.1 | 0.3 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.1 | 0.3 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 0.3 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.1 | 0.7 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.1 | 0.1 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 3.8 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.1 | 0.7 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.3 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.1 | 6.2 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.1 | 0.3 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.1 | 0.8 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 0.3 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.1 | 0.1 | GO:0071316 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) positive regulation of apoptotic process by virus(GO:0060139) cellular response to nicotine(GO:0071316) |
0.1 | 0.7 | GO:0006862 | nucleotide transport(GO:0006862) |
0.1 | 0.4 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.1 | 0.9 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.1 | 0.7 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.1 | 0.7 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.1 | 0.4 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.3 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.3 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.1 | 0.1 | GO:0070141 | response to UV-A(GO:0070141) |
0.1 | 1.9 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.1 | 0.8 | GO:0034434 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.1 | 1.3 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.1 | 0.1 | GO:2000765 | regulation of cytoplasmic translation(GO:2000765) |
0.1 | 0.8 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.1 | 0.3 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 3.5 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.1 | 0.4 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.1 | 0.2 | GO:1900372 | negative regulation of nucleotide biosynthetic process(GO:0030809) negative regulation of purine nucleotide biosynthetic process(GO:1900372) |
0.1 | 0.2 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.1 | 2.8 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
0.1 | 8.0 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.1 | 0.1 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.1 | 0.1 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.1 | 0.4 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.1 | 0.1 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.2 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.1 | 3.4 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.1 | 1.6 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.1 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.1 | 0.2 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.1 | 0.5 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.4 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.1 | 0.5 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 1.1 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 0.1 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.1 | 0.5 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) |
0.1 | 1.8 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 1.1 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 3.0 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.1 | 0.4 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.1 | 0.2 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.1 | 2.9 | GO:0098840 | intraciliary transport(GO:0042073) protein transport along microtubule(GO:0098840) |
0.1 | 0.2 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.1 | 0.3 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.7 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.1 | 0.1 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.1 | 1.4 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.1 | 0.3 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.1 | 3.7 | GO:1901659 | glycosyl compound biosynthetic process(GO:1901659) |
0.1 | 2.1 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.1 | 0.2 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.1 | 0.1 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.1 | 0.1 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.1 | 1.6 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.1 | 0.2 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.1 | 0.1 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.1 | 0.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 2.5 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.1 | 1.9 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.1 | 0.3 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.1 | 0.1 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.1 | 5.9 | GO:0051963 | regulation of synapse assembly(GO:0051963) |
0.1 | 0.7 | GO:0071450 | cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
0.1 | 0.2 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.1 | 1.7 | GO:0060325 | face morphogenesis(GO:0060325) |
0.1 | 0.5 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.2 | GO:0045842 | regulation of maintenance of sister chromatid cohesion(GO:0034091) positive regulation of maintenance of sister chromatid cohesion(GO:0034093) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.1 | 1.2 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 2.5 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.1 | 0.5 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 0.5 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.1 | 0.2 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.1 | 0.4 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.1 | 0.4 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.1 | 0.4 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.1 | 0.1 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.1 | 0.1 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
0.1 | 0.4 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.1 | 3.0 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.1 | 0.5 | GO:0061042 | vascular wound healing(GO:0061042) |
0.1 | 0.2 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 0.3 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 1.2 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.1 | 0.6 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.4 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.1 | 0.3 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.1 | 0.2 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.1 | 0.5 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.1 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.1 | 1.4 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.1 | 0.5 | GO:1903624 | regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
0.1 | 5.3 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 0.2 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 0.3 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.1 | 0.5 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
0.1 | 0.1 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.1 | 0.7 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.1 | 0.2 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.8 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 0.9 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.1 | 0.4 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.1 | 1.1 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
0.1 | 3.1 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.6 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 0.2 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.3 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.1 | 0.3 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.8 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 0.2 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.1 | 0.2 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.1 | 0.3 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.1 | 0.4 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.1 | 2.1 | GO:0006414 | translational elongation(GO:0006414) |
0.1 | 0.6 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.1 | 0.5 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.6 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.4 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.5 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.1 | 0.5 | GO:1901881 | positive regulation of protein depolymerization(GO:1901881) |
0.1 | 0.7 | GO:0031112 | positive regulation of microtubule polymerization or depolymerization(GO:0031112) |
0.1 | 0.3 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.1 | 0.1 | GO:0044838 | cell quiescence(GO:0044838) |
0.1 | 0.2 | GO:0019054 | modulation by virus of host process(GO:0019054) |
0.1 | 0.8 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.1 | 0.7 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.1 | 0.4 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 0.7 | GO:0030325 | adrenal gland development(GO:0030325) |
0.1 | 0.6 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.1 | 0.2 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.1 | 0.3 | GO:0006705 | mineralocorticoid biosynthetic process(GO:0006705) |
0.1 | 0.2 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.1 | 0.7 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.1 | 0.2 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.8 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.7 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.1 | 0.2 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.2 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 0.1 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.1 | GO:1901077 | regulation of relaxation of muscle(GO:1901077) |
0.1 | 0.3 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.1 | 0.8 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.1 | 0.3 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.1 | 0.1 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.1 | 0.3 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.1 | 4.6 | GO:0051297 | centrosome organization(GO:0051297) |
0.1 | 0.3 | GO:0048665 | neuron fate specification(GO:0048665) |
0.1 | 0.2 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.1 | 0.4 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.5 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.1 | 0.3 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 0.7 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.2 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.1 | 1.0 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.1 | 0.4 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 0.3 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.1 | 0.2 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 0.8 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.1 | 0.3 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.4 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.1 | 0.1 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.1 | 0.5 | GO:0030262 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.1 | 0.2 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.1 | 0.1 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
0.1 | 0.2 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.1 | 0.2 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
0.1 | 0.6 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.1 | 0.2 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.1 | 0.1 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.1 | 0.6 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.1 | 0.5 | GO:1902099 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.1 | 1.7 | GO:0001783 | B cell apoptotic process(GO:0001783) |
0.1 | 0.3 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.1 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 0.6 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.3 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.1 | 0.8 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.1 | 0.3 | GO:0070897 | DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.1 | 0.2 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.1 | 0.4 | GO:0044090 | positive regulation of vacuole organization(GO:0044090) |
0.1 | 0.1 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.1 | 0.2 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.1 | 0.5 | GO:0003203 | endocardial cushion morphogenesis(GO:0003203) |
0.1 | 0.5 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 0.5 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.2 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.1 | 0.1 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.1 | 0.6 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 0.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 5.4 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.1 | 0.1 | GO:0014717 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.1 | 0.1 | GO:0014028 | notochord formation(GO:0014028) |
0.1 | 0.2 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.1 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 1.1 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.1 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.1 | 0.4 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.1 | 0.1 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 0.1 | GO:0030038 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.1 | 0.1 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 0.4 | GO:0035384 | thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
0.1 | 0.2 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 0.2 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.1 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.1 | 0.1 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.1 | 0.2 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.1 | 0.1 | GO:0009218 | pyrimidine ribonucleotide metabolic process(GO:0009218) |
0.1 | 0.1 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.1 | 0.2 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.1 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.1 | 0.3 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.1 | 3.7 | GO:0051028 | mRNA transport(GO:0051028) |
0.1 | 0.9 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.1 | 0.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 0.3 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.2 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.1 | 0.4 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 0.1 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.1 | 0.1 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 0.2 | GO:0008589 | regulation of smoothened signaling pathway(GO:0008589) |
0.1 | 1.2 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 2.4 | GO:0042698 | ovulation cycle(GO:0042698) |
0.1 | 1.4 | GO:0032231 | regulation of actin filament bundle assembly(GO:0032231) |
0.1 | 1.2 | GO:0048286 | lung alveolus development(GO:0048286) |
0.1 | 0.1 | GO:0001660 | fever generation(GO:0001660) |
0.1 | 0.8 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.1 | 0.3 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.2 | GO:0009624 | response to nematode(GO:0009624) |
0.1 | 3.8 | GO:0006413 | translational initiation(GO:0006413) |
0.1 | 0.1 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 1.0 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 0.1 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.1 | 0.5 | GO:0071711 | basement membrane organization(GO:0071711) |
0.1 | 0.8 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 0.2 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.1 | 0.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 0.1 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.1 | 0.1 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.1 | 0.1 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.1 | 0.3 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.1 | 0.1 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.1 | 0.4 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.1 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
0.1 | 0.1 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.1 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 1.8 | GO:0006694 | steroid biosynthetic process(GO:0006694) |
0.1 | 0.2 | GO:0048313 | Golgi inheritance(GO:0048313) |
0.1 | 0.1 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.1 | 0.5 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
0.1 | 0.2 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.1 | 0.5 | GO:0072663 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.1 | 0.4 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.1 | 0.2 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.1 | 0.3 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 0.1 | GO:2000826 | regulation of heart morphogenesis(GO:2000826) |
0.1 | 0.2 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.1 | 0.3 | GO:0045072 | regulation of interferon-gamma biosynthetic process(GO:0045072) positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.1 | 0.9 | GO:0048255 | mRNA stabilization(GO:0048255) |
0.1 | 0.1 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.1 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.3 | GO:0051350 | negative regulation of lyase activity(GO:0051350) |
0.1 | 3.9 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.1 | 0.6 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.5 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.1 | 0.2 | GO:0035627 | ceramide transport(GO:0035627) |
0.1 | 0.2 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.1 | 0.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.2 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 0.2 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.1 | 0.5 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 0.2 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.3 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.1 | 0.1 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.1 | 0.1 | GO:0060914 | heart formation(GO:0060914) |
0.1 | 0.2 | GO:0042546 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.1 | 0.2 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.3 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.1 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) |
0.1 | 0.1 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
0.1 | 0.2 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.0 | 0.0 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.0 | 0.1 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.0 | 0.6 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.0 | 0.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.0 | GO:0046084 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.0 | 0.0 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.0 | 0.1 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.0 | 0.2 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.0 | 0.0 | GO:0055094 | response to lipoprotein particle(GO:0055094) |
0.0 | 0.1 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.0 | 0.1 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.0 | 0.0 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.0 | 0.4 | GO:0048701 | embryonic cranial skeleton morphogenesis(GO:0048701) |
0.0 | 0.3 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 0.1 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.0 | 0.0 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.0 | 0.1 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.0 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.0 | 0.1 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.0 | 0.0 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.1 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.0 | 0.3 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.0 | 0.0 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.0 | 0.1 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.0 | 0.0 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.0 | 0.0 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 0.6 | GO:0019228 | neuronal action potential(GO:0019228) |
0.0 | 0.8 | GO:0008542 | visual learning(GO:0008542) |
0.0 | 0.1 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.0 | 0.1 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.0 | 0.1 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.0 | 0.2 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.0 | 0.1 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
0.0 | 0.1 | GO:0090148 | membrane fission(GO:0090148) |
0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.1 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.0 | 0.0 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.0 | 0.1 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.0 | 0.2 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.6 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.0 | 0.0 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.0 | 0.0 | GO:0060312 | regulation of blood vessel remodeling(GO:0060312) |
0.0 | 0.1 | GO:0071554 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.1 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.0 | 0.2 | GO:0046931 | pore complex assembly(GO:0046931) |
0.0 | 0.2 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.0 | 0.9 | GO:0031960 | response to corticosteroid(GO:0031960) |
0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.2 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.2 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
0.0 | 0.4 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.2 | GO:0030890 | positive regulation of B cell proliferation(GO:0030890) |
0.0 | 0.0 | GO:0051150 | regulation of smooth muscle cell differentiation(GO:0051150) |
0.0 | 0.1 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.0 | 0.0 | GO:0051055 | negative regulation of lipid biosynthetic process(GO:0051055) |
0.0 | 0.1 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.0 | 0.3 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.0 | 0.1 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.0 | 0.2 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.0 | 0.3 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.1 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.0 | 0.0 | GO:0035989 | tendon development(GO:0035989) |
0.0 | 0.0 | GO:0034114 | regulation of heterotypic cell-cell adhesion(GO:0034114) |
0.0 | 0.2 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.0 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.0 | 0.1 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.0 | 0.1 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.0 | 0.0 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.0 | 0.0 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.0 | 0.1 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.0 | 0.1 | GO:0048532 | anatomical structure arrangement(GO:0048532) |
0.0 | 0.5 | GO:0042551 | neuron maturation(GO:0042551) |
0.0 | 0.0 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.0 | 0.1 | GO:0051256 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
0.0 | 0.2 | GO:1901655 | cellular response to ketone(GO:1901655) |
0.0 | 0.1 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.1 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.0 | 0.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.4 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.0 | 0.0 | GO:0007494 | midgut development(GO:0007494) |
0.0 | 0.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.0 | 0.7 | GO:0031497 | chromatin assembly(GO:0031497) |
0.0 | 0.4 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.1 | GO:0002067 | glandular epithelial cell differentiation(GO:0002067) |
0.0 | 0.1 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.0 | 0.2 | GO:0035307 | positive regulation of protein dephosphorylation(GO:0035307) |
0.0 | 0.0 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.0 | 0.1 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.0 | 0.1 | GO:0007567 | parturition(GO:0007567) |
0.0 | 3.5 | GO:0016042 | lipid catabolic process(GO:0016042) |
0.0 | 0.0 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.0 | 0.3 | GO:0021522 | spinal cord motor neuron differentiation(GO:0021522) |
0.0 | 1.8 | GO:0060041 | retina development in camera-type eye(GO:0060041) |
0.0 | 0.0 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.0 | 1.8 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.0 | 0.1 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.0 | 0.2 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.0 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.0 | 0.0 | GO:0031498 | chromatin disassembly(GO:0031498) |
0.0 | 0.1 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.0 | 0.0 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.1 | GO:0033700 | phospholipid efflux(GO:0033700) |
0.0 | 0.3 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.0 | 0.1 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
0.0 | 0.0 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.0 | 0.4 | GO:0035567 | non-canonical Wnt signaling pathway(GO:0035567) |
0.0 | 0.1 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 | 0.0 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.0 | 2.1 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
0.0 | 0.0 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.0 | 0.0 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) |
0.0 | 0.1 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.0 | 0.0 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.0 | 0.3 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.2 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.0 | 0.1 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.0 | 0.1 | GO:0051583 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) |
0.0 | 0.0 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.0 | 0.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.8 | GO:0007612 | learning(GO:0007612) |
0.0 | 0.1 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.0 | 0.1 | GO:0002716 | negative regulation of natural killer cell mediated immunity(GO:0002716) negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
0.0 | 0.1 | GO:0097421 | liver regeneration(GO:0097421) |
0.0 | 0.1 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.0 | 0.0 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.0 | 0.1 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.0 | 0.0 | GO:0051133 | regulation of NK T cell activation(GO:0051133) |
0.0 | 0.1 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.0 | 0.0 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.0 | 0.0 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.0 | 0.3 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.0 | 0.1 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.0 | 0.0 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.0 | 0.2 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.0 | 0.0 | GO:0031272 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) |
0.0 | 0.4 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.0 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.0 | 0.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.5 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.0 | 0.1 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.0 | 0.1 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.0 | 0.3 | GO:0035094 | response to nicotine(GO:0035094) |
0.0 | 0.0 | GO:0030421 | defecation(GO:0030421) |
0.0 | 0.3 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.3 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.0 | 0.1 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
0.0 | 0.1 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.0 | 0.2 | GO:0044259 | multicellular organismal macromolecule metabolic process(GO:0044259) |
0.0 | 0.1 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.0 | 0.1 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.0 | 0.1 | GO:0075733 | transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) multi-organism intracellular transport(GO:1902583) |
0.0 | 0.0 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.0 | 0.1 | GO:0010812 | negative regulation of cell-substrate adhesion(GO:0010812) |
0.0 | 0.0 | GO:0061384 | heart trabecula morphogenesis(GO:0061384) |
0.0 | 0.6 | GO:0071333 | cellular response to glucose stimulus(GO:0071333) |
0.0 | 0.1 | GO:0009168 | purine nucleoside monophosphate biosynthetic process(GO:0009127) purine ribonucleoside monophosphate biosynthetic process(GO:0009168) |
0.0 | 0.0 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.0 | 0.0 | GO:0015810 | aspartate transport(GO:0015810) |
0.0 | 0.0 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.0 | 0.0 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.1 | GO:0001707 | mesoderm formation(GO:0001707) |
0.0 | 0.0 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.0 | 0.1 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.0 | 0.0 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.0 | 0.2 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.0 | 0.4 | GO:0060828 | regulation of canonical Wnt signaling pathway(GO:0060828) |
0.0 | 0.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.1 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.0 | 0.1 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.0 | 0.1 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.0 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.0 | 0.1 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.0 | 0.0 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.0 | 0.1 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.0 | 0.1 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.0 | 0.1 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.0 | 0.0 | GO:0046878 | regulation of saliva secretion(GO:0046877) positive regulation of saliva secretion(GO:0046878) |
0.0 | 0.2 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.0 | 0.0 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.0 | 0.2 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.0 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 1.3 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
0.0 | 0.0 | GO:0045933 | positive regulation of muscle contraction(GO:0045933) |
0.0 | 0.0 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
0.0 | 0.0 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.0 | 0.1 | GO:0071709 | membrane assembly(GO:0071709) |
0.0 | 0.1 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.0 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.0 | 0.0 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.0 | 0.1 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.0 | 0.1 | GO:0045738 | negative regulation of DNA repair(GO:0045738) |
0.0 | 0.0 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) |
0.0 | 0.0 | GO:0030903 | notochord development(GO:0030903) |
0.0 | 0.0 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.0 | 0.0 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.0 | 0.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.0 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.1 | GO:0085029 | extracellular matrix assembly(GO:0085029) |
0.0 | 0.0 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 0.1 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.0 | 0.0 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.0 | 0.0 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.0 | 0.1 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.0 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.0 | 0.0 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.1 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.0 | GO:0003352 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
0.0 | 0.0 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.0 | 0.0 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.0 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.1 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.0 | 0.1 | GO:0007625 | grooming behavior(GO:0007625) |
0.0 | 0.2 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.0 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) |
0.0 | 0.0 | GO:0060323 | head morphogenesis(GO:0060323) |
0.0 | 0.0 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) negative regulation of cell killing(GO:0031342) |
0.0 | 0.0 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.0 | 0.0 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.0 | 0.1 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.0 | 0.1 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.0 | 0.0 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.0 | 0.0 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.0 | 0.0 | GO:0009838 | abscission(GO:0009838) |
0.0 | 0.0 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.0 | 0.0 | GO:0014002 | astrocyte development(GO:0014002) |
0.0 | 0.0 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.0 | 0.0 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.0 | 0.0 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.0 | 0.0 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.0 | 0.0 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.0 | 0.0 | GO:0060460 | left lung morphogenesis(GO:0060460) |
0.0 | 0.0 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.0 | 0.1 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.0 | 0.0 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.0 | 0.0 | GO:0032252 | secretory granule localization(GO:0032252) |
0.0 | 0.0 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.0 | 0.0 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.0 | 0.1 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.0 | 0.0 | GO:0001759 | organ induction(GO:0001759) |
0.0 | 0.0 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.0 | 0.0 | GO:0018101 | protein citrullination(GO:0018101) |
0.0 | 0.0 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 0.0 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.0 | 0.0 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.0 | 0.0 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.0 | 0.0 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.0 | 0.1 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.0 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.0 | 0.0 | GO:0071435 | potassium ion export(GO:0071435) |
0.0 | 0.0 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.0 | 0.0 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.0 | 0.0 | GO:0072102 | glomerulus morphogenesis(GO:0072102) |
0.0 | 0.1 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.0 | 0.1 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.0 | 0.0 | GO:0032770 | positive regulation of monooxygenase activity(GO:0032770) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.6 | 34.8 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
5.8 | 34.5 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
4.1 | 12.4 | GO:0055087 | Ski complex(GO:0055087) |
3.8 | 11.4 | GO:0097427 | microtubule bundle(GO:0097427) |
3.1 | 12.3 | GO:0032021 | NELF complex(GO:0032021) |
2.2 | 31.5 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
2.1 | 6.2 | GO:1990812 | growth cone filopodium(GO:1990812) |
1.9 | 7.8 | GO:0071797 | LUBAC complex(GO:0071797) |
1.8 | 7.1 | GO:0097452 | GAIT complex(GO:0097452) |
1.7 | 15.2 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
1.5 | 4.5 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
1.5 | 6.0 | GO:1990357 | terminal web(GO:1990357) |
1.5 | 7.4 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
1.4 | 12.6 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
1.4 | 1.4 | GO:0005915 | zonula adherens(GO:0005915) |
1.3 | 5.3 | GO:0036449 | microtubule minus-end(GO:0036449) |
1.3 | 3.9 | GO:0005594 | collagen type IX trimer(GO:0005594) |
1.3 | 52.4 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
1.3 | 3.8 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
1.2 | 7.4 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
1.2 | 4.9 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
1.2 | 4.9 | GO:0071953 | elastic fiber(GO:0071953) |
1.1 | 6.8 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
1.1 | 2.2 | GO:0044299 | C-fiber(GO:0044299) |
1.1 | 4.5 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
1.0 | 9.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
1.0 | 12.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
1.0 | 5.9 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.9 | 5.6 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.9 | 6.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.9 | 6.3 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.9 | 5.4 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.9 | 2.6 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.9 | 2.6 | GO:0000811 | GINS complex(GO:0000811) |
0.8 | 10.1 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.8 | 9.9 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.8 | 0.8 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.8 | 3.8 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.7 | 2.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.7 | 10.3 | GO:0031011 | Ino80 complex(GO:0031011) |
0.7 | 6.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.7 | 9.9 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.7 | 5.3 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.6 | 3.9 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.6 | 4.9 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.6 | 4.8 | GO:0036157 | outer dynein arm(GO:0036157) |
0.6 | 1.2 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.6 | 16.0 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.6 | 2.3 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.6 | 1.7 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.5 | 3.7 | GO:0042382 | paraspeckles(GO:0042382) |
0.5 | 1.5 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.5 | 1.0 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.5 | 8.7 | GO:0005614 | interstitial matrix(GO:0005614) |
0.5 | 0.5 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.5 | 1.5 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.5 | 1.5 | GO:0030056 | hemidesmosome(GO:0030056) |
0.5 | 1.5 | GO:0043511 | inhibin complex(GO:0043511) |
0.5 | 13.0 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.5 | 3.8 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.5 | 1.9 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.5 | 16.2 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.5 | 4.6 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.5 | 4.5 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.5 | 1.8 | GO:0005667 | transcription factor complex(GO:0005667) |
0.4 | 0.4 | GO:0071564 | npBAF complex(GO:0071564) |
0.4 | 3.0 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.4 | 0.4 | GO:0097513 | myosin II filament(GO:0097513) |
0.4 | 39.8 | GO:0005604 | basement membrane(GO:0005604) |
0.4 | 4.2 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.4 | 1.7 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.4 | 1.2 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.4 | 0.4 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.4 | 1.2 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.4 | 1.6 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.4 | 4.7 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.4 | 27.4 | GO:0000792 | heterochromatin(GO:0000792) |
0.4 | 5.6 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.4 | 39.2 | GO:0043204 | perikaryon(GO:0043204) |
0.4 | 8.9 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.4 | 16.7 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.4 | 3.2 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.4 | 1.1 | GO:0000125 | PCAF complex(GO:0000125) |
0.4 | 1.8 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.4 | 2.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.4 | 8.5 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.4 | 0.7 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.4 | 1.8 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.3 | 8.9 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.3 | 1.0 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.3 | 0.7 | GO:0070552 | BRISC complex(GO:0070552) |
0.3 | 5.7 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.3 | 1.0 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.3 | 5.7 | GO:0043034 | costamere(GO:0043034) |
0.3 | 4.0 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.3 | 9.9 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.3 | 3.3 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.3 | 5.9 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.3 | 2.9 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.3 | 1.9 | GO:0001939 | female pronucleus(GO:0001939) |
0.3 | 13.4 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.3 | 1.3 | GO:0097433 | dense body(GO:0097433) |
0.3 | 1.3 | GO:0042827 | platelet dense granule(GO:0042827) |
0.3 | 0.3 | GO:0031523 | Myb complex(GO:0031523) |
0.3 | 0.6 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.3 | 3.1 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.3 | 3.6 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.3 | 1.8 | GO:0043203 | axon hillock(GO:0043203) |
0.3 | 1.5 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.3 | 4.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.3 | 0.9 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.3 | 0.6 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.3 | 2.3 | GO:0070652 | HAUS complex(GO:0070652) |
0.3 | 5.8 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.3 | 0.8 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.3 | 0.3 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.3 | 4.8 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.3 | 2.4 | GO:0031932 | TORC2 complex(GO:0031932) |
0.3 | 0.5 | GO:0045180 | basal cortex(GO:0045180) |
0.3 | 12.7 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.3 | 2.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.3 | 1.3 | GO:0000796 | condensin complex(GO:0000796) |
0.3 | 0.8 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.2 | 2.2 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.2 | 0.2 | GO:0042585 | germinal vesicle(GO:0042585) |
0.2 | 14.8 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 9.6 | GO:0045171 | intercellular bridge(GO:0045171) |
0.2 | 0.7 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.2 | 1.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.2 | 0.7 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.2 | 0.9 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 1.2 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 0.2 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.2 | 15.3 | GO:0000502 | proteasome complex(GO:0000502) |
0.2 | 0.9 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.2 | 3.5 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.2 | 0.9 | GO:0045298 | tubulin complex(GO:0045298) |
0.2 | 0.7 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.2 | 2.4 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.2 | 0.2 | GO:0016939 | kinesin II complex(GO:0016939) |
0.2 | 0.6 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.2 | 1.5 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.2 | 0.4 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.2 | 0.6 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.2 | 0.6 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.2 | 0.2 | GO:0031512 | motile primary cilium(GO:0031512) |
0.2 | 1.2 | GO:0043194 | axon initial segment(GO:0043194) |
0.2 | 0.8 | GO:0061574 | ASAP complex(GO:0061574) |
0.2 | 10.7 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 0.6 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 2.0 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.2 | 1.8 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 2.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 0.6 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 0.6 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.2 | 1.1 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 0.2 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.2 | 0.9 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 0.9 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 0.4 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.2 | 1.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 0.7 | GO:0071203 | WASH complex(GO:0071203) |
0.2 | 1.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.2 | 5.6 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.2 | 0.5 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.2 | 0.5 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.2 | 0.3 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.2 | 0.5 | GO:0061617 | MICOS complex(GO:0061617) |
0.2 | 0.7 | GO:0042583 | chromaffin granule(GO:0042583) |
0.2 | 0.8 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.2 | 2.3 | GO:0031519 | PcG protein complex(GO:0031519) |
0.2 | 0.2 | GO:0042611 | MHC protein complex(GO:0042611) |
0.2 | 1.0 | GO:0016234 | inclusion body(GO:0016234) |
0.2 | 1.1 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.2 | 0.3 | GO:0033010 | paranodal junction(GO:0033010) |
0.2 | 7.7 | GO:0016605 | PML body(GO:0016605) |
0.2 | 1.7 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 0.3 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.2 | 46.6 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.2 | 1.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.2 | 0.6 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.2 | 1.2 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.1 | 4.7 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.1 | 0.4 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 1.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 1.9 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.8 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 0.4 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.1 | 2.0 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 0.4 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.1 | 0.9 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.1 | 3.0 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 2.9 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.1 | 0.7 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 6.5 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.1 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.6 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.5 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 0.6 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.1 | 0.4 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 1.3 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 0.7 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 0.3 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 0.6 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 0.3 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 0.2 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 8.0 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.1 | 0.1 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 0.9 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.3 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 0.8 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 3.2 | GO:0031256 | leading edge membrane(GO:0031256) |
0.1 | 4.1 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 1.9 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 3.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 1.4 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.1 | 3.9 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 1.2 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 4.7 | GO:0010008 | endosome membrane(GO:0010008) |
0.1 | 3.4 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 23.7 | GO:0005874 | microtubule(GO:0005874) |
0.1 | 0.7 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 0.3 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.1 | 2.4 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 0.5 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.1 | 2.6 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.4 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 0.3 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.1 | 11.6 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.1 | 0.4 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 0.5 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.4 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 0.9 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.9 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 7.3 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 4.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 3.5 | GO:0042383 | sarcolemma(GO:0042383) |
0.1 | 0.5 | GO:0000243 | commitment complex(GO:0000243) |
0.1 | 0.6 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 0.2 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 0.3 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.3 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.1 | 0.3 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.3 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.1 | 0.1 | GO:0097449 | astrocyte projection(GO:0097449) |
0.1 | 0.1 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.5 | GO:0005844 | polysome(GO:0005844) |
0.1 | 6.4 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.1 | 0.1 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 0.4 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.7 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 3.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 9.2 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.1 | 0.5 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 0.6 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 2.1 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.3 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.1 | 5.1 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 15.1 | GO:0097458 | neuron part(GO:0097458) |
0.1 | 0.2 | GO:0070069 | cytochrome complex(GO:0070069) |
0.1 | 0.6 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 282.3 | GO:0005634 | nucleus(GO:0005634) |
0.1 | 0.5 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 3.1 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.1 | 0.3 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 12.4 | GO:0045202 | synapse(GO:0045202) |
0.1 | 0.1 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 0.3 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 8.7 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 0.4 | GO:0019814 | immunoglobulin complex(GO:0019814) |
0.1 | 0.6 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 0.2 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.1 | 1.0 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 0.1 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 0.4 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.1 | GO:1990923 | PET complex(GO:1990923) |
0.0 | 0.0 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.0 | 35.6 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.1 | GO:0030684 | preribosome(GO:0030684) |
0.0 | 0.2 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 3.3 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 7.3 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.9 | GO:0034705 | potassium channel complex(GO:0034705) |
0.0 | 3.4 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.2 | GO:0030496 | midbody(GO:0030496) |
0.0 | 1.7 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.2 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 2.4 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.0 | 0.1 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.1 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.1 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 0.1 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.1 | GO:0000785 | chromatin(GO:0000785) |
0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.1 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.0 | GO:0044393 | microspike(GO:0044393) |
0.0 | 0.0 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.1 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.0 | 0.1 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.0 | 0.1 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.0 | GO:0044447 | axoneme part(GO:0044447) |
0.0 | 0.0 | GO:0051286 | cell tip(GO:0051286) |
0.0 | 0.0 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.0 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.0 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.0 | 0.0 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.0 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 0.0 | GO:0042589 | zymogen granule membrane(GO:0042589) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.1 | 131.0 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
10.0 | 30.0 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
5.7 | 17.0 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
3.4 | 16.8 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
3.2 | 29.1 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
2.6 | 20.7 | GO:0035197 | siRNA binding(GO:0035197) |
2.5 | 7.5 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
2.5 | 12.4 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
2.3 | 4.5 | GO:0070840 | dynein complex binding(GO:0070840) |
2.1 | 43.1 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
1.9 | 5.8 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
1.9 | 9.3 | GO:0042609 | CD4 receptor binding(GO:0042609) |
1.9 | 11.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
1.8 | 12.9 | GO:0050700 | CARD domain binding(GO:0050700) |
1.8 | 5.5 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
1.7 | 5.2 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.7 | 5.1 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
1.7 | 5.0 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
1.7 | 6.6 | GO:0033142 | progesterone receptor binding(GO:0033142) |
1.7 | 18.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
1.6 | 22.6 | GO:0070628 | proteasome binding(GO:0070628) |
1.6 | 31.7 | GO:0003785 | actin monomer binding(GO:0003785) |
1.6 | 9.5 | GO:0015288 | porin activity(GO:0015288) |
1.5 | 6.1 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
1.5 | 4.5 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
1.4 | 5.7 | GO:0032051 | clathrin light chain binding(GO:0032051) |
1.4 | 15.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
1.4 | 11.0 | GO:0004017 | adenylate kinase activity(GO:0004017) |
1.4 | 6.8 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
1.3 | 17.5 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
1.3 | 6.7 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.3 | 5.4 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
1.3 | 10.7 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
1.3 | 1.3 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
1.3 | 16.7 | GO:0070402 | NADPH binding(GO:0070402) |
1.2 | 2.4 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
1.2 | 5.8 | GO:0070061 | fructose binding(GO:0070061) |
1.0 | 3.1 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
1.0 | 2.1 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
1.0 | 3.0 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
1.0 | 9.0 | GO:0034783 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
1.0 | 11.0 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.9 | 12.3 | GO:0070403 | NAD+ binding(GO:0070403) |
0.9 | 0.9 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.9 | 4.3 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.9 | 2.6 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.9 | 4.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.8 | 10.5 | GO:0015643 | toxic substance binding(GO:0015643) |
0.8 | 15.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.8 | 4.0 | GO:0043559 | insulin binding(GO:0043559) |
0.8 | 3.1 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.8 | 3.9 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.8 | 40.6 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.7 | 10.1 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.7 | 2.2 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.7 | 7.8 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.7 | 2.8 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.7 | 6.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.7 | 18.6 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.7 | 1.4 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.7 | 2.8 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.7 | 3.4 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.7 | 2.7 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.7 | 8.7 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.7 | 2.0 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.7 | 13.1 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.6 | 1.9 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.6 | 5.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.6 | 14.1 | GO:0030332 | cyclin binding(GO:0030332) |
0.6 | 1.9 | GO:0008948 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) oxaloacetate decarboxylase activity(GO:0008948) |
0.6 | 2.5 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.6 | 0.6 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.6 | 12.0 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.6 | 3.6 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.6 | 1.8 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.6 | 3.6 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.6 | 8.9 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.6 | 2.3 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.6 | 1.1 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.6 | 1.7 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.6 | 0.6 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.6 | 3.9 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.6 | 1.7 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.6 | 1.1 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.5 | 0.5 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.5 | 3.7 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.5 | 4.3 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.5 | 2.6 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.5 | 3.7 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.5 | 1.6 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.5 | 9.9 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.5 | 2.6 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.5 | 2.0 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.5 | 0.5 | GO:0051373 | FATZ binding(GO:0051373) |
0.5 | 2.0 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.5 | 1.5 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.5 | 1.0 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.5 | 2.9 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.5 | 1.4 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.5 | 10.9 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.4 | 6.7 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.4 | 0.9 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.4 | 40.2 | GO:0060090 | binding, bridging(GO:0060090) |
0.4 | 0.4 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.4 | 3.4 | GO:0015266 | protein channel activity(GO:0015266) |
0.4 | 2.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.4 | 6.7 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.4 | 13.0 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.4 | 1.6 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.4 | 5.7 | GO:0030275 | LRR domain binding(GO:0030275) |
0.4 | 7.3 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.4 | 2.8 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.4 | 2.0 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.4 | 1.2 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.4 | 3.2 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.4 | 2.4 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.4 | 1.6 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.4 | 0.8 | GO:0048495 | Roundabout binding(GO:0048495) |
0.4 | 1.6 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.4 | 1.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.4 | 0.8 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.4 | 1.1 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.4 | 10.6 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.4 | 1.9 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.4 | 0.7 | GO:0048030 | disaccharide binding(GO:0048030) |
0.4 | 1.4 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.4 | 1.4 | GO:0015265 | urea channel activity(GO:0015265) |
0.4 | 1.4 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.4 | 1.4 | GO:0045340 | mercury ion binding(GO:0045340) |
0.3 | 0.7 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.3 | 5.2 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.3 | 2.4 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.3 | 1.0 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.3 | 0.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.3 | 1.7 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.3 | 2.7 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.3 | 2.3 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.3 | 3.3 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.3 | 5.9 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.3 | 1.3 | GO:1990254 | keratin filament binding(GO:1990254) |
0.3 | 3.6 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.3 | 1.3 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.3 | 1.0 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.3 | 2.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.3 | 1.9 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.3 | 3.9 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.3 | 12.2 | GO:0035064 | methylated histone binding(GO:0035064) |
0.3 | 5.1 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.3 | 6.0 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.3 | 0.3 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.3 | 1.9 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.3 | 0.6 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.3 | 2.2 | GO:0031432 | titin binding(GO:0031432) |
0.3 | 1.2 | GO:0043515 | kinetochore binding(GO:0043515) |
0.3 | 2.4 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.3 | 13.9 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.3 | 1.2 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.3 | 5.7 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.3 | 1.2 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.3 | 0.3 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.3 | 1.2 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.3 | 0.9 | GO:0019862 | IgA binding(GO:0019862) |
0.3 | 0.6 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.3 | 0.3 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.3 | 0.8 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.3 | 0.3 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.3 | 11.4 | GO:0000049 | tRNA binding(GO:0000049) |
0.3 | 0.8 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.3 | 1.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.3 | 12.1 | GO:0002039 | p53 binding(GO:0002039) |
0.3 | 0.5 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.3 | 1.3 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.3 | 1.6 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.3 | 1.9 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.3 | 7.2 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.3 | 0.8 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.3 | 3.4 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.3 | 1.3 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.3 | 0.8 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.3 | 0.3 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.3 | 15.7 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.3 | 2.1 | GO:0008430 | selenium binding(GO:0008430) |
0.3 | 2.6 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.3 | 1.8 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.3 | 23.9 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.3 | 0.8 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.3 | 0.5 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.2 | 2.2 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.2 | 0.7 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.2 | 1.0 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.2 | 49.7 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.2 | 15.7 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 0.2 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.2 | 2.2 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.2 | 0.7 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 1.9 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.2 | 0.5 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.2 | 0.9 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 0.7 | GO:0043888 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.2 | 0.7 | GO:0030984 | kininogen binding(GO:0030984) |
0.2 | 1.6 | GO:0005536 | glucose binding(GO:0005536) |
0.2 | 0.4 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
0.2 | 1.8 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 7.4 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.2 | 0.9 | GO:0031013 | troponin I binding(GO:0031013) |
0.2 | 1.5 | GO:0005542 | folic acid binding(GO:0005542) |
0.2 | 12.6 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.2 | 0.6 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.2 | 0.4 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.2 | 0.6 | GO:0042731 | PH domain binding(GO:0042731) |
0.2 | 0.8 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 1.7 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.2 | 1.0 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) potassium ion antiporter activity(GO:0022821) |
0.2 | 1.7 | GO:0010181 | FMN binding(GO:0010181) |
0.2 | 1.8 | GO:0051378 | serotonin binding(GO:0051378) |
0.2 | 0.4 | GO:0055100 | adiponectin binding(GO:0055100) |
0.2 | 1.0 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.2 | 0.4 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.2 | 2.2 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.2 | 1.0 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.2 | 1.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.2 | 1.4 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.2 | 0.4 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.2 | 3.0 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.2 | 0.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 0.2 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.2 | 0.4 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.2 | 0.4 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.2 | 0.6 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.2 | 1.0 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.2 | 2.7 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 1.5 | GO:0039706 | co-receptor binding(GO:0039706) |
0.2 | 0.8 | GO:0002054 | nucleobase binding(GO:0002054) |
0.2 | 0.9 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.2 | 0.4 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.2 | 0.9 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.2 | 0.9 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.2 | 2.6 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 2.9 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 0.7 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.2 | 2.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 0.7 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.2 | 0.9 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.2 | 0.9 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.2 | 0.5 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.2 | 0.2 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.2 | 1.9 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.2 | 1.5 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.2 | 1.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 0.3 | GO:0035870 | dITP diphosphatase activity(GO:0035870) |
0.2 | 0.8 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 12.1 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.2 | 2.7 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.2 | 2.7 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.2 | 1.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.2 | 1.0 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 1.3 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.2 | 0.6 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.2 | 1.0 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 0.5 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.2 | 1.0 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 0.6 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 29.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 15.7 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.2 | 3.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.2 | 1.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.2 | 1.1 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.2 | 2.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.2 | 0.5 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.2 | 0.8 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.2 | 0.5 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.2 | 2.1 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.2 | 1.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.2 | 0.5 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 0.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.6 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.1 | 0.1 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 75.1 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 3.2 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 9.3 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.4 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.1 | 0.7 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.1 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.1 | 0.1 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.1 | 0.4 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.6 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 0.7 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 1.3 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.1 | 18.0 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.1 | 2.3 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 1.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.7 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.3 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.4 | GO:0098631 | protein binding involved in cell adhesion(GO:0098631) |
0.1 | 0.5 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 6.8 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.1 | 8.3 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.8 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 2.3 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.1 | 0.6 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.4 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.1 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 0.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 0.1 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.1 | 5.6 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 0.4 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 0.4 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 1.5 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.8 | GO:0030553 | cGMP binding(GO:0030553) |
0.1 | 0.6 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.1 | 0.2 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.1 | 0.2 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.1 | 2.1 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 10.3 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 0.8 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 0.7 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.1 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 0.6 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 0.2 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 10.4 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 0.2 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.1 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 0.7 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.3 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.1 | 2.6 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 5.9 | GO:0009055 | electron carrier activity(GO:0009055) |
0.1 | 0.5 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.3 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 2.6 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.8 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.1 | 50.7 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.1 | 0.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 0.3 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 0.4 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 2.4 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 0.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 1.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.1 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 1.0 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 0.3 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 1.4 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 0.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.8 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 1.2 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.3 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.9 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 0.9 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 0.5 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.3 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.2 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 0.2 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.1 | 0.2 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 0.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.1 | 0.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.2 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 2.0 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 0.6 | GO:0071814 | lipoprotein particle binding(GO:0071813) protein-lipid complex binding(GO:0071814) |
0.1 | 0.3 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 0.4 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.1 | 1.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 0.3 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.1 | 0.3 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 2.6 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.1 | 4.7 | GO:0005262 | calcium channel activity(GO:0005262) |
0.1 | 2.2 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.4 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 1.5 | GO:0032442 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity(GO:0000252) mevaldate reductase activity(GO:0004495) gluconate dehydrogenase activity(GO:0008875) epoxide dehydrogenase activity(GO:0018451) 5-exo-hydroxycamphor dehydrogenase activity(GO:0018452) 2-hydroxytetrahydrofuran dehydrogenase activity(GO:0018453) acetoin dehydrogenase activity(GO:0019152) phenylcoumaran benzylic ether reductase activity(GO:0032442) D-xylose:NADP reductase activity(GO:0032866) L-arabinose:NADP reductase activity(GO:0032867) D-arabinitol dehydrogenase, D-ribulose forming (NADP+) activity(GO:0033709) (R)-(-)-1,2,3,4-tetrahydronaphthol dehydrogenase activity(GO:0034831) 3-hydroxymenthone dehydrogenase activity(GO:0034840) very long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0035380) (R)-2-hydroxyisocaproate dehydrogenase activity(GO:0043713) L-arabinose 1-dehydrogenase (NADP+) activity(GO:0044103) L-xylulose reductase (NAD+) activity(GO:0044105) 3-ketoglucose-reductase activity(GO:0048258) D-arabinitol dehydrogenase, D-xylulose forming (NADP+) activity(GO:0052677) |
0.1 | 0.3 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 1.0 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.8 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.4 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 2.3 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.1 | 0.5 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.1 | 1.6 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.1 | 0.5 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.1 | 5.4 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
0.1 | 0.4 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 0.3 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.1 | 0.4 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.4 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 21.1 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 0.3 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 0.3 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 1.2 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.4 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.7 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 1.3 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.2 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.1 | 1.2 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.1 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.1 | 1.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 1.3 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.1 | 0.1 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.1 | 0.1 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.1 | 0.7 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.2 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.1 | 0.2 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 1.1 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.1 | 0.3 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.2 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.2 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.1 | 0.1 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.2 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 1.9 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 0.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 1.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 1.0 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.2 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.2 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 0.1 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.1 | 0.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 0.1 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 8.7 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) |
0.1 | 1.4 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 4.5 | GO:0003774 | motor activity(GO:0003774) |
0.1 | 0.1 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 1.6 | GO:0019905 | syntaxin binding(GO:0019905) |
0.1 | 1.6 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.1 | 12.3 | GO:0044212 | transcription regulatory region DNA binding(GO:0044212) |
0.1 | 0.1 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.1 | 0.1 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.1 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.1 | 0.1 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.1 | 0.3 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.1 | 0.3 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.1 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.3 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.1 | 2.8 | GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity(GO:0008757) |
0.1 | 0.1 | GO:2001070 | starch binding(GO:2001070) |
0.1 | 0.1 | GO:0019201 | nucleotide kinase activity(GO:0019201) |
0.1 | 0.6 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.2 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.2 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 0.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.2 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.1 | 0.1 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.1 | 0.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.1 | 0.1 | GO:0031402 | sodium ion binding(GO:0031402) |
0.1 | 0.5 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 0.2 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 0.1 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.1 | 0.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 2.3 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 2.5 | GO:0003682 | chromatin binding(GO:0003682) |
0.1 | 0.7 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.6 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.1 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.1 | 0.1 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.1 | 0.5 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.4 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 0.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.1 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.1 | 0.1 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 0.2 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 0.2 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.1 | 5.0 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 1.4 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 0.2 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.0 | 0.0 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.0 | 0.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.2 | GO:0048038 | quinone binding(GO:0048038) |
0.0 | 0.0 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.0 | 0.1 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.0 | 0.3 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 0.4 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) purine-specific mismatch base pair DNA N-glycosylase activity(GO:0000701) single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.0 | 0.4 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.1 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.0 | 0.1 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.0 | 0.1 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.0 | 0.1 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.0 | 0.2 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.3 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.0 | 0.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.0 | 0.4 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 1.2 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.0 | 2.7 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.0 | 4.1 | GO:0003729 | mRNA binding(GO:0003729) |
0.0 | 2.9 | GO:0008092 | cytoskeletal protein binding(GO:0008092) |
0.0 | 1.2 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 0.3 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.0 | 0.8 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.6 | GO:0034792 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.0 | 0.2 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.0 | 0.1 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.0 | 0.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.7 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.3 | GO:0015925 | galactosidase activity(GO:0015925) |
0.0 | 0.5 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 0.1 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.0 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.0 | 0.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.0 | 0.0 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.1 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.0 | 0.2 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.0 | 0.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 0.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 8.4 | GO:0017111 | nucleoside-triphosphatase activity(GO:0017111) |
0.0 | 0.4 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.0 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.0 | 2.9 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.0 | 0.0 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.6 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.0 | GO:0005165 | neurotrophin receptor binding(GO:0005165) |
0.0 | 6.9 | GO:0005198 | structural molecule activity(GO:0005198) |
0.0 | 0.0 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.0 | 0.2 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.2 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.2 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.0 | 0.1 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 2.1 | GO:0008017 | microtubule binding(GO:0008017) |
0.0 | 0.4 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 18.9 | GO:0003677 | DNA binding(GO:0003677) |
0.0 | 0.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.4 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 3.2 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 0.0 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.0 | 0.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.0 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.5 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.1 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 0.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.0 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.0 | 0.2 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 0.0 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.0 | 0.5 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.0 | 0.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.0 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.0 | 0.3 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.4 | GO:0005272 | sodium channel activity(GO:0005272) |
0.0 | 0.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 0.0 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.0 | 3.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.0 | GO:0015172 | acidic amino acid transmembrane transporter activity(GO:0015172) |
0.0 | 0.1 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.0 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.1 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.0 | 0.0 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.0 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.0 | 0.1 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 0.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.2 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 0.2 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.0 | 0.4 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 1.9 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 0.0 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.0 | 0.0 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.0 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.2 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.0 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 1.4 | GO:0051020 | GTPase binding(GO:0051020) |
0.0 | 0.1 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.1 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.1 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.1 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.0 | 0.0 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.0 | 0.0 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 0.0 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.0 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 0.2 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.2 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.0 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.0 | 0.0 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.0 | GO:0070697 | activin receptor binding(GO:0070697) |
0.0 | 0.0 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 0.1 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.0 | 0.0 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 0.1 | GO:0042562 | hormone binding(GO:0042562) |
0.0 | 0.2 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.0 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 0.0 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.1 | GO:0016454 | C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.0 | GO:0019863 | IgE binding(GO:0019863) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 11.3 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.8 | 25.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.8 | 3.1 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.8 | 36.5 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.7 | 10.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.6 | 21.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.6 | 11.2 | PID ARF 3PATHWAY | Arf1 pathway |
0.6 | 14.0 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.5 | 1.5 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.5 | 4.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.4 | 6.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.4 | 23.0 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.4 | 3.4 | PID IGF1 PATHWAY | IGF1 pathway |
0.4 | 5.4 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.4 | 19.5 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.4 | 10.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.3 | 11.9 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.3 | 2.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.3 | 0.3 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.3 | 6.1 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.3 | 8.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.3 | 12.5 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.3 | 10.7 | PID INSULIN PATHWAY | Insulin Pathway |
0.3 | 8.8 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 1.4 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.3 | 0.5 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.2 | 3.9 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 3.8 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 1.4 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.2 | 2.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 7.4 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 6.7 | NABA COLLAGENS | Genes encoding collagen proteins |
0.2 | 4.6 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.2 | 6.3 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.2 | 31.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 0.4 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.2 | 1.6 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 3.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 1.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 5.0 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 5.3 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.2 | 1.4 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.2 | 3.1 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.2 | 2.4 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 2.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 1.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 1.7 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 6.9 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.2 | 2.6 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 0.6 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 2.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 8.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 0.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 0.4 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.1 | 4.9 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 0.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 1.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 0.8 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 1.1 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 14.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 1.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 1.7 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 1.4 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 0.4 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 0.6 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 1.0 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 0.4 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 0.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 2.4 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 0.3 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 0.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 1.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 0.6 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 0.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 17.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.7 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 0.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 1.2 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 0.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 0.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 0.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 1.5 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 2.0 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 0.5 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.7 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 0.8 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 1.4 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.0 | 1.2 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.2 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.5 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.8 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 1.0 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.8 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.2 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.2 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.3 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.0 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.2 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 13.9 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
1.4 | 89.7 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
1.4 | 9.6 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
1.3 | 20.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
1.3 | 11.8 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
1.0 | 12.7 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.9 | 9.3 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.9 | 18.7 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.9 | 8.8 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.8 | 9.1 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.7 | 15.0 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.7 | 7.4 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.7 | 2.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.6 | 5.8 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.6 | 8.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.6 | 11.1 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.6 | 5.4 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.6 | 9.0 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.5 | 24.1 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.5 | 1.1 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.5 | 1.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.5 | 9.0 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.5 | 13.1 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.5 | 14.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.5 | 4.6 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.5 | 5.6 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.5 | 0.5 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.5 | 4.0 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.5 | 10.7 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.5 | 20.1 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.5 | 0.9 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.5 | 3.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.4 | 10.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.4 | 4.3 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.4 | 4.7 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.4 | 8.0 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.4 | 6.7 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.4 | 1.2 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.4 | 3.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.4 | 9.7 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.3 | 3.8 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.3 | 1.7 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.3 | 3.7 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.3 | 3.1 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.3 | 3.3 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.3 | 8.4 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.3 | 6.0 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.3 | 0.3 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.3 | 2.8 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.3 | 1.2 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.3 | 8.0 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.3 | 1.2 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.3 | 2.7 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.3 | 3.3 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.3 | 4.0 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.3 | 0.3 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.3 | 2.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.3 | 3.8 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.3 | 3.0 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.3 | 0.8 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.3 | 0.5 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.3 | 4.0 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.2 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 1.4 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.2 | 9.5 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.2 | 9.7 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.2 | 2.4 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.2 | 6.4 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.2 | 1.9 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.2 | 1.0 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.2 | 6.9 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 8.0 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 1.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.2 | 0.2 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.2 | 0.3 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.2 | 1.5 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.2 | 0.8 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.2 | 11.4 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.2 | 3.7 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.2 | 5.1 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 1.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 7.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 12.9 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 0.7 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.1 | 1.8 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 0.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 0.7 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.1 | 0.3 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.1 | 0.4 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.1 | 1.2 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 0.6 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 3.0 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 2.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 1.5 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 1.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 1.9 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 1.4 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 1.3 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 1.9 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.1 | 1.9 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 1.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 15.7 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 0.3 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 7.1 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.4 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 2.0 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 1.2 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 0.9 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 1.9 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.1 | 0.7 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 1.0 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.1 | 1.1 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 0.7 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 1.0 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 2.5 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 0.7 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 2.2 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.1 | 0.2 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 4.5 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 1.0 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 1.2 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 1.0 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 1.8 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 1.7 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 0.2 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.1 | 2.5 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 0.5 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 1.2 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 0.5 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 0.4 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 0.2 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.1 | 0.2 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 1.4 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 1.8 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 0.4 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 2.1 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 0.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 0.6 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 0.1 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.1 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 0.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 1.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 0.5 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 0.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 0.2 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 0.2 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 1.3 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 0.8 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 1.3 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 0.6 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 0.8 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.6 | REACTOME BASE EXCISION REPAIR | Genes involved in Base Excision Repair |
0.0 | 0.8 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.3 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.1 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 1.4 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.0 | 2.2 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.0 | 0.8 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.0 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.0 | 0.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 3.5 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.0 | 0.7 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.0 | 0.1 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.1 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 1.1 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 1.3 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.4 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.5 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.8 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.1 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.3 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.0 | 0.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.1 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.0 | 0.2 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.0 | 0.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 1.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.1 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.0 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 0.1 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.0 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |